🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Medico Remedies Limited MEDICO NSEPHARMA

Healthcare · Drug Manufacturers - Specialty & Generic · India
https://medicoremedies.com

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and steroidal preparations. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India.

READ MORE ›
₹47.67
-14.65% 1Y

Market & Price

Market Cap
₹395.58 Cr
Current Price
₹47.67
High / Low (52W)
₹55.85 / ₹32.76
Beta
0.56

Valuation

Stock P/E
30.17
Industry PE
37.60
Forward P/E
-
PEG Ratio
-
Book Value
₹9.15
Price to Book
5.21
P/S
1.92
EV/EBITDA
24.00
Dividend Yield
-

Profitability & Returns

ROCE
26.22%
ROE
19.02%
ROA
6.38%
Profit Margin
6.35%
Op Margin
11.18%
EPS (Latest Qtr)
₹0.71
EPS (TTM)
₹1.58

Balance Sheet & Liquidity

Debt/Equity
0.25
Quick Ratio
1.10
Current Ratio
1.66
Debt
₹19.20 Cr
Total Assets
₹153.40 Cr
Current Assets
₹128.92 Cr
Working Capital
₹51.27 Cr

Ownership

Promoter Holding
69.45%
Chg in Prom Hold
-
FII / Inst Holding
0.00%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
₹408.67 Cr
Total Revenue (TTM)
₹206.38 Cr
EBITDA
₹17.03 Cr
Free Cash Flow
₹-8.76 Cr
Operating Cash Flow
₹5.87 Cr
Shares Outstanding
₹8.30 Cr
Gross Margin
26.67%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
14.22%
Profit 5Y
21.89%
Revenue (YoY)
37.50%
Earnings (YoY)
36.50%

PROS

  • Healthy ROCE of 26.2%.
  • Compounding revenue at 14.2% over 5 years.
  • Profit CAGR of 21.9% over 5 years.

CONS

  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

NSE TradingView Screener.in

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 MEDICO Medico Remedies Limited NSEPHARMA 47.67 30.17 ₹395.58 Cr - 26.22% 19.02% 14.22% 21.89%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,799.20 37.59 ₹4.32 L Cr 0.92% 17.94% 14.72% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 6,667.00 68.97 ₹1.77 L Cr 0.45% 18.96% 16.19% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,410.80 68.96 ₹1.49 L Cr 0.86% 9.06% 16.98% 13.27% 20.21%
5 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,401.00 29.16 ₹1.13 L Cr 0.93% 14.88% 11.74% 7.23% 11.45%
6 DRREDDY Dr. Reddy's Laboratories Limited NIFTY50NSEAIPHARMA 1,303.50 25.90 ₹1.09 L Cr 0.61% 14.00% 11.83% 10.96% -2.35%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,077.70 21.51 ₹1.08 L Cr 0.09% 19.24% 18.32% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,267.70 19.49 ₹1.04 L Cr 0.53% 28.42% 26.91% 19.10% 131.46%
9 MANKIND Mankind Pharma Limited NIFTY_MIDNSEPHARMA 2,375.60 51.29 ₹98,090.71 Cr 0.08% 13.78% 12.45% 17.73% 14.28%
⚙Ad space

Quarterly Results

Figures in INR.

Metric Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue --41.30 Cr38.25 Cr52.64 Cr58.68 Cr56.81 Cr
Cost of Revenue --27.36 Cr27.34 Cr40.44 Cr44.11 Cr39.44 Cr
Gross Profit --13.94 Cr10.91 Cr12.19 Cr14.57 Cr17.37 Cr
Operating Expenses --8.04 Cr8.86 Cr10.21 Cr11.03 Cr11.02 Cr
Operating Income --5.90 Cr2.06 Cr1.98 Cr3.54 Cr6.35 Cr
EBITDA --6.96 Cr3.48 Cr4.44 Cr5.01 Cr10.02 Cr
Interest Expense --49.40 L28.11 L23.51 L38.63 L90.38 L
Pretax Income --5.70 Cr2.43 Cr3.47 Cr3.83 Cr8.32 Cr
Tax Provision --1.36 Cr61.58 L90.59 L96.00 L2.46 Cr
Net Income --4.34 Cr1.82 Cr2.57 Cr2.87 Cr5.86 Cr
Diluted EPS 0.19-0.520.220.310.350.71

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue -138.50 Cr143.31 Cr150.94 Cr206.38 Cr
Cost of Revenue -112.73 Cr118.60 Cr108.33 Cr151.33 Cr
Gross Profit -25.77 Cr24.71 Cr42.61 Cr55.05 Cr
Operating Expenses -18.87 Cr14.68 Cr30.64 Cr41.12 Cr
Operating Income -6.90 Cr10.03 Cr11.97 Cr13.93 Cr
EBITDA -16.12 Cr14.86 Cr17.69 Cr22.96 Cr
Interest Expense -58.04 L64.25 L1.16 Cr1.81 Cr
Pretax Income -10.10 Cr11.33 Cr13.50 Cr18.06 Cr
Tax Provision -2.86 Cr3.04 Cr3.41 Cr4.94 Cr
Net Income -7.24 Cr8.29 Cr10.09 Cr13.12 Cr
Diluted EPS 0.580.871.001.22-

Compounded Sales Growth

5 Years:14.22%
1 Year:37.50%

Compounded Profit Growth

5 Years:21.89%
1 Year:36.50%

Stock Price Performance

1 Year:-14.65%
6 Months:-2.73%
3 Months:+0.02%
1 Month:+17.41%

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -87.45 Cr96.20 Cr119.80 Cr153.40 Cr
Current Assets -64.54 Cr73.71 Cr96.68 Cr128.92 Cr
Cash & Equivalents -91.14 L18.27 L1.09 Cr1.91 Cr
Inventory -19.70 Cr16.34 Cr26.73 Cr30.02 Cr
Receivables -36.09 Cr49.63 Cr57.18 Cr81.99 Cr
Total Liabilities -43.61 Cr43.82 Cr57.33 Cr77.93 Cr
Current Liabilities -41.77 Cr42.81 Cr56.96 Cr77.64 Cr
Long Term Debt -00028.63 L
Total Debt -9.76 Cr8.05 Cr14.70 Cr19.20 Cr
Total Equity -43.84 Cr52.37 Cr62.47 Cr75.47 Cr
Shares Outstanding -8.30 Cr8.30 Cr8.30 Cr8.30 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -8.17 Cr2.44 Cr4.89 Cr5.87 Cr
Investing Cash Flow --6.60 Cr-2.68 Cr-3.46 Cr-4.51 Cr
Financing Cash Flow --1.82 Cr-49.00 L-52.00 L-55.00 L
Capital Expenditure --6.59 Cr-2.48 Cr-3.19 Cr-4.49 Cr
Free Cash Flow -1.57 Cr-4.04 L1.70 Cr1.38 Cr
Net Change in Cash --25.36 L-72.87 L91.22 L81.19 L

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -18.6%17.2%28.2%26.7%
Operating Margin % -5.0%7.0%7.9%6.8%
Net Margin % -5.2%5.8%6.7%6.4%
ROE % -16.5%15.8%16.2%17.4%
ROCE % -15.1%18.8%19.1%18.4%

Shareholding Pattern

Insiders
69.45%
Institutions
0.00%
Public Float
0.00%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for MEDICO

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space